KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Net Margin Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,250.00
Dec 31, 2025 1,080.00
Sep 30, 2025 -1,659.00
Jun 30, 2025 1,342.00
Mar 31, 2025 -2,526.00
Dec 31, 2024 -3,233.00
Sep 30, 2024 -1,140.00
Jun 30, 2024 52.00
Mar 31, 2024 -2,023.00
Dec 31, 2023 2,775.00
Sep 30, 2023 -2,057.00
Jun 30, 2023 -934.00
Mar 31, 2023 -3,587.00
Dec 31, 2022 1,568.00
Sep 30, 2022 336.00
Jun 30, 2022 -2,121.00
Mar 31, 2022 702.00
Dec 31, 2021 671.00
Sep 30, 2021 -267.00
Jun 30, 2021 -1,962.00
Mar 31, 2021 442.00
Dec 31, 2020 -2,358.00
Sep 30, 2020 -306.00
Jun 30, 2020 -128,395.00
Mar 31, 2020 1,465.00
Dec 31, 2019 4,704.00
Sep 30, 2019 1,214.00
Jun 30, 2019 -1,331.00
Mar 31, 2019 990.00
Dec 31, 2018 -4,406.00
Sep 30, 2018 1,266.00
Jun 30, 2018 119.00
Mar 31, 2018 1,272.00
Dec 31, 2017 -2,891.00
Sep 30, 2017 -1,184.00
Jun 30, 2017 -62.00
Mar 31, 2017 501.00